ViroAb™ Human Anti-MERS-CoV Spike Monoclonal Antibody (XS-0234), Fc Engineered

example

Documents

  • Datasheet

  • MSDS

  • COA

    Certificate of Analysis Lookup

    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

    Lot Number

  • Tech Support

Cat#: VRS-0224-YT1031

ViroAb™ Human Anti-MERS-CoV Spike Monoclonal Antibody (XS-0234), Fc Engineered

This Human Monoclonal antibody is specific for MERS-CoV Spike protein. The antibody can be used for applications: Block, Neut. The antibody is for Middle East Respiratory Syndromedisease research use only and is not approved for use in humans or in clinical diagnosis.

Made to Order Requirements

Unconjugated

0.1 mg

Your choose infomation:

 CLEAR

(Note: Please select the requirements to fit you project. If you have any other requirements, please specify. If no specific requirements, you don't need to select any button.)

  • Product Overview
  • Product Properties
  • Packaging, Storage & Formulations
  • Applications

Product Overview

Target : S
Target Specific Region : S1
Specificity : This antibody specifically binds the amino acids 349-590 in the S1 domain of the MERS-CoV.
Clone : XS-0234
Host Species : Human
Antibody Isotype : IgG1(Fc Engineered), Kappa
Species Reactivity : MERS-COV

Product Properties

Immunogen : The original antibody was generated by isolating neutralizing antibodies from a non-immune human Ab-phage library using a novel panning strategy.
Purity : >95% as determined by SDS-PAGE
Purification : Protein A affinity chromatography
Concentration : 1.0 mg/mL (lot specific)

Packaging, Storage & Formulations

Form : Liquid
Formulation : PBS, 0.02% Proclin 300
Preservative : 0.02% Proclin 300
Storage : Store at 4°C for short term. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application : Neut
Application Notes : This antibody was created using our proprietary engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors.
This antibody blocks the binding of MERS-CoV spike protein to DPP4 receptor by binding to the aa 349-590 in the S1 domain of the MERS-CoV. The optimal working dilutions should be determined by the end user.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.


Inquiry Basket